Hansa Biopharma AB (STU:24H) Shares Buyback Ratio % : -25.10 (As of Dec. 12, 2024)

View and export this data going back to 2016. Start your Free Trial

What is Hansa Biopharma AB Shares Buyback Ratio %?

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

GuruFocus calculates shares buyback ratio using previous shares outstanding minus the current shares outstanding, and then divides by previous shares outstanding. Hansa Biopharma AB's current shares buyback ratio was -25.10%.

Hansa Biopharma AB Shares Buyback Ratio % Historical Data

The historical data trend for Hansa Biopharma AB's Shares Buyback Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hansa Biopharma AB Shares Buyback Ratio % Chart

Hansa Biopharma AB Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Shares Buyback Ratio %

Get a 7-Day Free Trial

-0.17

-11.11

-17.92

-0.43

Hansa Biopharma AB Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Shares Buyback Ratio %	Get a 7-Day Free Trial															-	-0.43	-	-24.54	-0.01

Hansa Biopharma AB Shares Buyback Ratio % Calculation

Hansa Biopharma AB's Shares Buyback Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Shares Buyback Ratio	=	(Shares Outstanding (EOP) (A: Dec. 2022 )	-	Shares Outstanding (EOP) (A: Dec. 2023 ))	/	Shares Outstanding (EOP) (A: Dec. 2022 )
	=	(52.444	-	52.6718)	/	52.444
	=	-0.43%

Hansa Biopharma AB's Shares Buyback Ratio for the quarter that ended in Sep. 2024 is calculated as

Shares Buyback Ratio	=	(Shares Outstanding (EOP) (A: Jun. 2024 )	-	Shares Outstanding (EOP) (A: Sep. 2024 ))	/	Shares Outstanding (EOP) (A: Jun. 2024 )
	=	(65.6	-	65.6096)	/	65.6
	=	-0.01%

Hansa Biopharma AB Shares Buyback Ratio % Related Terms

Thank you for viewing the detailed overview of Hansa Biopharma AB's Shares Buyback Ratio % provided by GuruFocus.com. Please click on the following links to see related term pages.

Hansa Biopharma AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hansa Biopharma AB (STU:24H) » Definitions » Shares Buyback Ratio %

Comparable Companies

Traded in Other Exchanges

HNSBF:USA HNSA:Sweden 0RC7:UK 24H:Germany

Address

Scheelevagen 22, Lund, SWE, 223 63

Website

https://www.hansabiopharma.com

Hansa Biopharma AB is a biopharmaceutical company that develops immunomodulatory treatments for enabling transplantations and rare immunoglobulin G (IgG)-mediated autoimmune conditions, transplant rejection, and cancer. The company's product candidate, imlifidase, is an antibody-cleaving enzyme being developed to enable kidney transplantation in sensitized patients and further developed for use in other organ and tissue transplantation as well as acute autoimmune indications. It operates in Sweden, other European countries, and the U.S. The group generates the majority of its revenue from product sales.

Hansa Biopharma AB Headlines

No Headlines